Literature DB >> 19194793

Expression of herpes simplex virus type 1 DNA polymerase by recombinant vaccinia virus.

Ralf Kronenwett1, Klaus Weisshart, Charles W Knopf.   

Abstract

We have studied expression of the catalytic subunit of a phosphonoacetic acid-resistant (PAA(r)) DNA polymerase (Pol) of herpes simplex virus type 1 (HSV-1) strain ANG by recombinant vaccinia virus (VV) engineered with the dominant Ecogpt selection system. In agreement with the vector construction recombinant Pol expression was regulated like a VV late function. De novo-synthesis of the 136-kDa Pol polypeptide was detectable as early as 6 h postinfection, peaked between 10 and 12 h, and correlated with specific polymerase activity. Compared with HSV-1 lytic infection, the recombinant Pol protein exhibited a reduced stability with a half-life of 7 h. Whereas the Pol-associated exonuclease activities, determined from lysates of recombinant VV- and HSV-1-infected cells, were almost identical, the polymerizing activity of recombinant Pol ceased after 10 min of incubation, in correlation with the fact that Pol depends on its cofactor for optimal chain elongation. Kinetics of cellular localization, tracked by a monospecific Pol antibody, revealed that the catalytic subunit initially assembled to a few dot-like nuclear sites, reminiscent of HSV-1 DNA replication compartments. Later during infection, the localization of recombinant Pol matched with that found in lytically HSV-1-infected cells. This study demonstrates that nuclear transport and localization of the Pol subunit is independent of herpesviral functions, and neither requires the presence of herpesviral DNA sequences. Recombinant VV provides a promising alternative to explore protein interactions of the herpesviral replication machinery in their authentic cellular environment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19194793     DOI: 10.1007/s11262-009-0330-9

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.198


  46 in total

1.  The herpes simplex virus type 1 UL42 gene product: a subunit of DNA polymerase that functions to increase processivity.

Authors:  J Gottlieb; A I Marcy; D M Coen; M D Challberg
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

2.  The herpes simplex virus type 1 DNA polymerase gene: site of phosphonoacetic acid resistance mutation in strain Angelotti is highly conserved.

Authors:  C W Knopf
Journal:  J Gen Virol       Date:  1987-05       Impact factor: 3.891

3.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

4.  Regulation of expression and nucleotide sequence of a late vaccinia virus gene.

Authors:  J P Weir; B Moss
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

5.  Interaction of herpes simplex virus type 1 DNA polymerase and the UL42 accessory protein with a model primer template.

Authors:  J Gottlieb; M D Challberg
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

6.  Mechanisms of antiviral immunity induced by a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: cytotoxic T cells.

Authors:  S Martin; B Moss; P W Berman; L A Laskey; B T Rouse
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

Review 7.  Vaccinia virus vectors: new strategies for producing recombinant vaccines.

Authors:  D E Hruby
Journal:  Clin Microbiol Rev       Date:  1990-04       Impact factor: 26.132

8.  Antibody response and protective capacity of plasmid vaccines expressing three different herpes simplex virus glycoproteins.

Authors:  P H Nass; K L Elkins; J P Weir
Journal:  J Infect Dis       Date:  1998-09       Impact factor: 5.226

9.  Oncolytic vaccinia virus: from bedside to benchtop and back.

Authors:  Steve H Thorne
Journal:  Curr Opin Mol Ther       Date:  2008-08

10.  Purification of the herpes simplex virus type 1 65-kilodalton DNA-binding protein: properties of the protein and evidence of its association with the virus-encoded DNA polymerase.

Authors:  M L Gallo; D H Jackwood; M Murphy; H S Marsden; D S Parris
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.